Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 12, 2016 4:26 PM ET

Capital Markets

Company Overview of StemGen, Inc.

Company Overview

StemGen, Inc. operates as a business advisory services company in the United States. The company facilitates the process of target leads and vetting potential investments in its targets. StemGen, Inc. has a license with SOKAP, which provide geo-targeting software platform for use in the acquisition of targets. The company was formerly known as Amasys Corporation and changed its name to StemGen, Inc. in December 2012. StemGen, Inc. was incorporated in 1992 and is based in Houston, Texas.

800 Town and Country Boulevard

Suite 300

Houston, TX 77024

United States

Founded in 1992

1 Employees



Key Executives for StemGen, Inc.

Chairman, Chief Executive Officer, President, Treasurer and Secretary
Age: 58
Total Annual Compensation: $42.2K
Compensation as of Fiscal Year 2015.

StemGen, Inc. Key Developments

StemGen, Inc. announced delayed annual 10-K filing

On 09/29/2015, StemGen, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

StemGen, Inc. Announces Management Changes

StemGen, Inc. announced that board of directors appointed John David Walls as chief executive officer and president. Mr. Walls was also appointed to serve as a director. Mr. Walls has not been appointed to any committees of the board, as the board does not presently have any committees. Mr. Walls brings 30 years of management and banking expertise to the company. From 2004 until 2014, he served as chief financial officer of a private manufacturing and tool company in Forney, Texas. Additionally, Mr. Robert J. Wilson resigned from all positions held with the company in order to pursue other interests.

StemGen, Inc. announced delayed 10-Q filing

On 11/17/2014, StemGen, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Similar Private Companies By Industry

Company Name Region
Universal Partners, Inc. United States
Aardvark LP United States
Meristem, LLP United States
Prestige Financial Center, Inc United States
Castle Creek Financial LLC United States

Recent Private Companies Transactions

Private Placement
March 6, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact StemGen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at